Article Text
Perspective
Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout
Statistics from Altmetric.com
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
Footnotes
-
Competing interests None.